Olympus has announced its 1Q financial results for FY2025
Posted:
The forward-looking statements, including forecast of financial results, contained in these materials are based on information currently available to the Company. See the full report and presentation here.
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.